Figure 5From: Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patientsCause specific survival. The overall median CSS was 6.3 months with a 6-month and 12-month actuarial rates of 53.8% and 23.1%, respectively.Back to article page